Impax Asset Management Group plc Raises Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Impax Asset Management Group plc raised its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 154.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 548,132 shares of the pharmacy operator’s stock after acquiring an additional 332,967 shares during the quarter. Impax Asset Management Group plc owned approximately 0.06% of Walgreens Boots Alliance worth $12,190,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also modified their holdings of the business. EverSource Wealth Advisors LLC lifted its stake in shares of Walgreens Boots Alliance by 308.4% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 845 shares in the last quarter. China Universal Asset Management Co. Ltd. lifted its stake in shares of Walgreens Boots Alliance by 273.2% during the 2nd quarter. China Universal Asset Management Co. Ltd. now owns 974 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 713 shares in the last quarter. Spotlight Asset Group Inc. purchased a new position in shares of Walgreens Boots Alliance during the 2nd quarter valued at $28,000. FinTrust Capital Advisors LLC lifted its stake in shares of Walgreens Boots Alliance by 2,314.5% during the 3rd quarter. FinTrust Capital Advisors LLC now owns 1,328 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 1,273 shares in the last quarter. Finally, Milestone Investment Advisors LLC purchased a new position in shares of Walgreens Boots Alliance during the 1st quarter valued at $31,000. Hedge funds and other institutional investors own 57.92% of the company’s stock.

Walgreens Boots Alliance Stock Performance

Shares of WBA opened at $22.76 on Wednesday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.30 and a current ratio of 0.66. The stock has a market capitalization of $19.63 billion, a P/E ratio of 34.48, a P/E/G ratio of 1.39 and a beta of 0.75. The company’s fifty day moving average is $23.51 and its two-hundred day moving average is $24.01. Walgreens Boots Alliance, Inc. has a 1 year low of $19.68 and a 1 year high of $37.96.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last posted its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $0.66 earnings per share for the quarter, topping analysts’ consensus estimates of $0.62 by $0.04. Walgreens Boots Alliance had a net margin of 0.40% and a return on equity of 10.48%. The business had revenue of $36.70 billion for the quarter, compared to analysts’ expectations of $34.95 billion. During the same period in the prior year, the company posted $1.16 EPS. The business’s revenue for the quarter was up 9.9% on a year-over-year basis. On average, sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 3.28 earnings per share for the current year.

Walgreens Boots Alliance Cuts Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 12th. Shareholders of record on Tuesday, February 20th will be issued a $0.25 dividend. The ex-dividend date of this dividend is Friday, February 16th. This represents a $1.00 dividend on an annualized basis and a yield of 4.39%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 290.91%.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on WBA shares. StockNews.com started coverage on shares of Walgreens Boots Alliance in a report on Thursday, October 5th. They issued a “hold” rating on the stock. TheStreet upgraded shares of Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a report on Monday, January 8th. JPMorgan Chase & Co. upgraded shares of Walgreens Boots Alliance from a “neutral” rating to an “overweight” rating and upped their price target for the company from $27.00 to $30.00 in a report on Monday, October 23rd. Truist Financial cut their price target on shares of Walgreens Boots Alliance from $30.00 to $25.00 and set a “hold” rating on the stock in a report on Wednesday, October 11th. Finally, Royal Bank of Canada cut their price target on shares of Walgreens Boots Alliance from $29.00 to $26.00 and set a “sector perform” rating on the stock in a report on Friday, October 13th. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $28.25.

Check Out Our Latest Stock Report on Walgreens Boots Alliance

Insider Buying and Selling at Walgreens Boots Alliance

In related news, CEO Timothy C. Wentworth acquired 10,000 shares of the business’s stock in a transaction dated Friday, January 5th. The shares were acquired at an average cost of $24.22 per share, for a total transaction of $242,200.00. Following the acquisition, the chief executive officer now directly owns 585,122 shares in the company, valued at approximately $14,171,654.84. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other Walgreens Boots Alliance news, CEO Timothy C. Wentworth bought 10,000 shares of the company’s stock in a transaction that occurred on Friday, January 5th. The stock was purchased at an average price of $24.22 per share, with a total value of $242,200.00. Following the transaction, the chief executive officer now owns 585,122 shares in the company, valued at $14,171,654.84. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Nancy M. Schlichting sold 15,209 shares of the stock in a transaction that occurred on Tuesday, January 16th. The shares were sold at an average price of $23.05, for a total transaction of $350,567.45. The disclosure for this sale can be found here. 17.40% of the stock is owned by insiders.

About Walgreens Boots Alliance

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Read More

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.